A prospective, randomized trial of intrathecal injection vs. Epidural infusion in the selection of patients for continuous intrathecal opioid therapy

Neuromodulation

Volumn 6, Issue 3, 2003, Pages 142-152

  Anderson, Valerie C ^a   Burchiel, Kim J ^a   Cooke, Beverly ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Analgesia; Chronic pain; Intrathecal opioid; Low back pain; Randomized

Indexed keywords

OPIATE;

ADULT; AGED; ANALGESIA; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAPHORESIS; DRUG COST; DRUG SAFETY; EDEMA; FEMALE; HEADACHE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; HYPOTENSION; INJECTION PAIN; LONG TERM CARE; MALE; MOOD; NAUSEA; PAIN ASSESSMENT; PATIENT SELECTION; PROSPECTIVE STUDY; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; URINE RETENTION; VOMITING;

EID: 0042303897     PISSN: 10947159     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1403.2003.03023.x     Document Type: Article

References (30)

1. Waldman SD, Leak DW, Kennedy LD, Patt RB. Intraspinal opioid therapy. In: Patt, RB, ed. Cancer Pain. Philadelphia: J.B. Lippincott, 1993:285-328.
2. Van Dongen RT, Crul BJ, De Bock M. Long-term intrathecal infusion of morphine and morphine/bupivacaine mixtures in the treatment of cancer pain: a retrospective analysis of 51 cases. Pain 1993;55:119-123.
3. Paice JA, Cohen FL. Validity of a verbally administered numeric rating scale to measure cancer pain intensity. Cancer Nurs 1997;20:88-93.
4. Jacox A, Carr D, Payne R et al. Management of Cancer Pain. Rockville, MD: US Department of of Health and Human Services, 1994 Clinical Practice Guideline no. 94-0592.
5. American Association of Neurosurgical Surgeons. Consensus Conference on the Neurosurgical Management of Pain. 63rd Annual Meeting, Orlando, FL, 1995.
6. Anderson VC, Burchiel KJ. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 1999;44:289-301.
7. Hassenbusch SJ, Stanton-Hicks M, Covington EC, Walsh JG, Guthrey DS. Long-term intraspinal infusions of opioids in the treatment of neuropathic pain. J Pain Symptom Manage 1995;10:527-543.
8. Winkelmuller M, Winkelmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996;85:458-467.
9. Krames E, Lanning R. Intrathecal infusional analgesia for nonmalignant pain. Analgesic efficacy of intrathecal opioid with or without bupivacaine. J Pain Symptom Manage 1993;8:539-548.
10. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic pain: a retrospective, multicenter study. J Pain Symptom Manage 1996;11:71-80.
11. Nitescu P, Appelgren L, Linder LE, Sjöberg M, Hultman E, Curelaru I. Epidural versus intrathecal morphine-bupivacaine. assessment of consecutive treatments in advanced cancer pain. J Pain Symptom Manage 1990;5:18-26.
12. Cherny N, Chang V, Frager G et al. Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration. Cancer 1995;76:1283-1293.
13. Steedman S, Middaugh S, Kee W, Carson D, Harden R, Miller M. Chronic-pain medications. Equivalence levels and method of quantifying usage. Clin J Pain 1992;8:204-214.
14. Guck T, Fleischer T, Willcockson J, Criscuolo C, Leibrock L. Predictive validity of the pain and impairment relationship scale in a chronic nonmalignant pain population. Arch Phys Med Rehab 1999;80:91-95.
15. Price DD, McGrath PA, Rafii A, Buckingham B. The validation of the visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983;17:45-56.
16. Jensen M, Turner J, Romano J, Fisher L. Comparative reliability and validity of chronic pain intensity measures. Pain 1999;83:157-162.
17. Katz J, Melzack R. Measurement of pain. Surg Clin NAm 1999;79:231-252.
18. Melzack R. The McGill Pain Questionnaire. major properties and scoring methods. Pain 1975;1:277-299.
19. Moore K, Stanley R, Burrows G. Profile of Mood States: Australian normative data. Psychol Rep 1990;66:509-510.
20. Nyenhuis D, Yamamoto C, Luchetta T, Terrien A, Parmentier A. Adult and geriatric normative data and validation of the profile of mood states. J Clin Psychol 1999;55:79-86.
21. Lindgren K, Masten V, Tiburzi M, Ford D, Bleecker M. The factor structure of the Profile of Mood States (POMS) and its relationship to occupational lead exposure. J Occ Environ Med 1999;41:3-10.
22. Deyo R. Comparative validity of the sickness impact profile and shorter scales for functional assessment in low-back pain. Spine 1986;11:951-954.
23. Katz J, Larson M, Phillips C, Fossel A, Liang M. Comparative measurement sensitivity of short and longer health status instruments. Med Care 1992;30:917-924.
24. Hassenbusch SJ. Epidural and subarachnoid administration of opioids for nonmalignant pain: technical issues, current approaches and novel treatments. J Pain Symptom Manage 1996;11:357-362.
25. Dawson-Saunders B, Trapp RG. Basic and Clinical Biostatistics. Norwalk, CT. Appleton-Lange, 1990.
26. McQuay HJ, Moore RA. An Evidence-Based Resource for Pain Relief. Oxford: Oxford University Press, 1998.
27. Belgrade MJ. Opioids for chronic nonmalignant pain. Choosing suitable candidates for long-term therapy. Postgrad Med 1999;106:119-124.
28. Vanegas G, Ripamonte C, Sbanotto A, De Conno F. Side effects of morphine administration in cancer patients. Cancer Nurs 1998;21:289-297.
29. Portenoy RK. Tolerance to opioid analgesics: clinical aspects. Cancer Surv 1994;21:49-65.
30. Portenoy RK. Management of common opioid side effects during long-term therapy of cancer pain. Ann Acad Med Singapore 1994;23:160-170.